Refractec Names Vice President of Marketing.Business Editors &Health/Medical Writers IRVINE, Calif.--(BW HealthWire)--Jan. 31, 2000 Refractec Inc. announced that its board of directors has named Lauren Kanner as vice president of marketing. Kanner joined the company last year to assist in commercializing the ViewPoint(TM) CK System, a device used to perform Conductive Keratoplasty Conductive keratoplasty (CK) is a type of refractive surgery that uses radio waves to adjust the contour of the cornea by shrinking the corneal collagen around it. It is used to treat mild to moderate hyperopia. It is a non-invasive alternative to other types of eye surgery. for the treatment of hyperopia hyperopia (hī'pərō`pēə): see farsightedness. . According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Mitchell B. Campbell, president and chief executive officer of Refractec, &uot;Lauren has made a valuable contribution in developing the Clinical Research, Education and Marketing functions for Refractec. &uot;She has been an integral part of the Refractec team and has been instrumental in developing positive relationships with key ophthalmic surgeons. Naming her vice president reflects her experience within the ophthalmic industry and commitment to Refractec.&uot; Kanner has worked for more than 15 years in the ophthalmic industry for Allergan, Summit Technology and Bausch &Lomb (formerly Chiron Vision) where she held several positions in marketing, clinical research and clinical education. Most recently she served as global product director for Chiron Vision for eight years where she was responsible for worldwide marketing of Chiron's cataract devices. During her tenure at Chiron, she worked on several award-winning campaigns and successfully increased Chiron's U.S. market share. Refractec is currently conducting Phase III clinical trials in the United States for Conductive Keratoplasty (CK), a minimally invasive non-laser approach for correcting low to moderate hyperopia. The potential refractive refractive capacity to refract light. refractive error a difference between the focal length of the cornea and lens, and the length of the eye, resulting in myopia or hyperopia. procedure market for CK with the Refractec Corneal corneal pertaining to the cornea. See also keratitis, keratopathy. corneal anomaly includes microcornea, coloboma, megalocornea, dermoid, congenital opacity. corneal black body see corneal sequestrum (below). Shaping (RCS (1) (Remote Computer Service) A remote timesharing service. (2) (Revision Control System) A Unix utility that provides version control. RCS - Revision Control System (TM)) System includes: low to moderate hyperopia, presbyopia Presbyopia Definition The term presbyopia means "old eye" and is a vision condition involving the loss of the eye's ability to focus on close objects. , astigmatism astigmatism (əstĭg`mətĭz'əm), type of faulty vision caused by a nonuniform curvature in the refractive surfaces—usually the cornea, less frequently the lens—of the eye. , and eyes that have been overcorrected by other refractive treatments. Industry analysts project that approximately 90 million Americans suffer from these conditions. According to Michael Moretti of Medical Insight Inc., a consulting firm based in Mission Viejo, Calif., approximately 1.5 million vision correction procedures will be performed this year in the United States, generating more than $2.5 billion in gross revenues for refractive surgeons and vision correction clinics. Other companies participating in the vision correction market include: Bausch &Lomb, Sunrise Technologies, KeraVision, Summit Technology and VISX. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion